Newsroom Categories: Pressemitteilungen

  • McDermott Represents Multicoin Capital in Formation of $430 Million Venture Fund III

    McDermott Represents Multicoin Capital in Formation of $430 Million Venture Fund III

    DEAL RELEASE / PRESSEMITTEILUNGEN

    McDermott Represents Multicoin Capital in Formation of $430 Million Venture Fund III

    July 19, 2022

    Read time: 3 min

    International law firm McDermott Will & Emery represented Multicoin Capital, a thesis-driven investment firm that invests in cryptocurrencies, tokens and blockchain companies, in the formation of Venture Fund III, which closed with capital commitments of $430 million. The fund will provide capital for early- and later-stage projects focused on data-aggregating decentralized autonomous organizations, open finance, Web3 infrastructure and consumer social opportunities, among other initiatives.

    The McDermott team was led by David Solander and included Rafael Calatrava, John Lutz, Andrew Granek and Todd Solomon.

    Read Multicoin’s press release.

    About Us

    McDermott Will & Emery partners with leaders around the world to fuel missions, knock down barriers and shape markets. Our team works seamlessly across practices, industries and more than 20 locations to deliver highly effective solutions that propel success. More than 1,200 lawyers strong, we bring our personal passion and legal prowess to bear in every matter for our clients and the people they serve.

    Wir empfehlen Ihnen ebenfalls

  • McDermott Represents Quote.com in Acquisition of Ring2Media Inc.

    McDermott Represents Quote.com in Acquisition of Ring2Media Inc.

    DEAL RELEASE / PRESSEMITTEILUNGEN

    McDermott Represents Quote.com in Acquisition of Ring2Media Inc.

    July 12, 2022

    Read time: 3 min

    International law firm McDermott Will & Emery represented Quote.com, a portfolio company of Osceola Capital, in its acquisition of Ring2Media Inc., a direct response marketing agency specializing in Medicare enrollment. The acquisition will be consolidated under the Quote.com brand and accelerate the company’s highly strategic Medicare segment.

    • The Ring2Media acquisition further diversifies Quote.com’s core digital product offering by adding expertise in TV/OTT marketing, expanding the company’s reach and addressable audience.
    About Us

    McDermott Will & Emery partners with leaders around the world to fuel missions, knock down barriers and shape markets. Our team works seamlessly across practices, industries and more than 20 locations to deliver highly effective solutions that propel success. More than 1,200 lawyers strong, we bring our personal passion and legal prowess to bear in every matter for our clients and the people they serve.

    Wir empfehlen Ihnen ebenfalls

  • McDermott Represents Wentworth Management Services LLC in its Business Combination with Kingswood Acquisition Corp.

    McDermott Represents Wentworth Management Services LLC in its Business Combination with Kingswood Acquisition Corp.

    DEAL RELEASE / PRESSEMITTEILUNGEN

    McDermott Represents Wentworth Management Services LLC in its Business Combination with Kingswood Acquisition Corp.

    July 8, 2022

    Read time: 3 min

    International law firm McDermott Will & Emery represented Wentworth Management Services LLC (Wentworth), a holding company that acquires and manages businesses in the wealth management industry, in a business combination agreement with Kingswood Acquisition Corp. (KWAC), a blank check company. The merger will create Binah Capital Group, Inc., where Wentworth and KWAC will become wholly owned subsidiaries.

    • The transaction was announced July 7, 2022, and is expected to close in the fourth quarter of 2022, subject to customary closing requirements.
    • This deal allows Wentworth to go public, giving them access to public equity markets.
    • The combined entity is expected to encompass over 1,900 advisors, $25 billion in assets under management and over $285 billion in affiliated assets under management. The combined company will have a pro forma enterprise value of $208 million.
    • The McDermott team was led by Griffin Doty and Ari Edelman and included Rodrigo Castello Branco, Anand Saha, Caroline Sandy and Tipanun Bisalbutr. Jerry Sokol is the relationship partner for Wentworth.
    • Read the press release.
    About Us

    McDermott Will & Emery partners with leaders around the world to fuel missions, knock down barriers and shape markets. With more than 20 locations on three continents, our team works seamlessly across practices, industries and geographies to deliver highly effective solutions that propel success. More than 1,200 lawyers strong, we bring our personal passion and legal prowess to bear in every matter for our clients and the people they serve.

    Wir empfehlen Ihnen ebenfalls

  • McDermott berät Ryvu Therapeutics bei Lizenzkooperation mit Exelixis

    DEAL RELEASE / PRESSEMITTEILUNGEN

    McDermott berät Ryvu Therapeutics bei Lizenzkooperation mit Exelixis

    7. Juli 2022

    Read time: 3 min

    Frankfurt a.M., 7. Juli 2022 – McDermott Will & Emery hat die polnische Ryvu Therapeutics S.A. beim Abschluss einer exklusiven Lizenzkooperation mit dem US-amerikanischen Arzneimittelforschungsunternehmen Exelixis, Inc. beraten.

    Ryvu vergibt an Exelixis eine Lizenz für seine STING-Technologie (STimulator of INterferon Genes) mit dem Ziel der Entwicklung neuartiger Krebstherapien. Exelixis erweitert durch die Lizenzvereinbarung ihr Biotherapeutika-Portfolio.

    Im Rahmen der Vereinbarung zahlt Exelixis an Ryvu eine Vorauszahlung in Höhe von drei Millionen US-Dollar und erhält im Gegenzug bestimmte Rechte an den Molekülen des STING-Agonisten von Ryvu. Ryvu stellt zudem fachliche Beratung und Know-how zur Verfügung und hat Anspruch auf Meilensteinzahlungen für Entwicklung, Zulassung und Vermarktung sowie auf gestaffelte Lizenzgebühren auf den jährlichen Nettoumsatz aller Produkte, die im Rahmen der Zusammenarbeit erfolgreich vermarktet werden.

    Die börsengelistete Ryvu Therapeutics S.A. mit Hauptsitz in Krakau konzentriert sich auf Arzneimittelforschung und -entwicklung, insbesondere auf neuartige niedermolekulare Krebstherapien. Die am weitesten fortgeschrittenen Programme von Ryvu sind RVU120 und SEL24 (MEN1703).

    Exelixis ist ein 1994 gegründetes auf Onkologie spezialisiertes Biotechnologieunternehmen mit Sitz in Alameda, Kalifornien.

    Berater Ryvu Therapeutics S.A.:
    McDermott Will & Emery, Frankfurt: Dr. Monika Emilia Richter (Counsel, Life Sciences/Transactions)

    About Us

    McDermott Will & Emery eine international führende Anwaltssozietät mit über 1.200 Anwältinnen und Anwälten an Standorten in Europa, Nordamerika und Asien. Wir arbeiten mit Führungskräften auf der ganzen Welt zusammen, um Missionen voranzutreiben, Barrieren zu überwinden und Märkte zu gestalten – unabhängig von Praxis- und Branchengrenzen. Unsere Anwältinnen und Anwälte decken mit ihrer Beratung das gesamte Spektrum des Wirtschafts- und Unternehmensrechts ab. Die deutsche Praxis wird von der McDermott Will & Emery Rechtsanwälte Steuerberater LLP geführt.

    Dr. Monika Emilia Richter

    Partnerin

    Frankfurt

    Wir empfehlen Ihnen ebenfalls

  • McDermott Will & Emery berät Swiss Life beim Kauf des 73.200 m² großen Areals in Düsseldorf von METRO PROPERTIES

    DEAL RELEASE / PRESSEMITTEILUNGEN

    McDermott Will & Emery berät Swiss Life beim Kauf des 73.200 m² großen Areals in Düsseldorf von METRO PROPERTIES

    5. Juli 2022

    Read time: 3 min

    Düsseldorf 05. Juli 2022 – McDermott Will & Emery hat Swiss Life beim Kauf des 73.200 m² großen Areal in Düsseldorf von METRO PROPERTIES beraten.

    Das von Swiss Life Asset Managers erworbene Areal ist aktuell Teil des METRO Campus, Swiss Life Asset Managers wird das innerstädtische Areal künftig unter einem neuen Namen gestalten und ein urbanes Quartier entwickeln. Es wird neben Wohnungen sowohl Flächen für Gewerbe, für Restaurants und Geschäfte als auch Raum für altersgerechtes Wohnen und Pflege geben. Öffentliche Flächen, eine KITA und eine Grundschule sind ebenso fester Bestandteil der Planung – alles vereint unter Erfüllung höchster ESG-Standards. Am 30. Juni 2022 erfolgte die notarielle Beurkundung der Transaktion durch das Notariat Droste + Haibt in Düsseldorf.

    Berater Swiss Life – McDermott Will & Emery: Dr. Ulrich Flege und Dr. Jens Ortmanns (Partner, beide Federführung, Real Estate, Düsseldorf), Dr. Florian Schiefer (Partner, Steuerrecht, Frankfurt am Main), Dr. Alexa Ningelgen (Partner, Öffentliches Recht, Düsseldorf), Alina Affeld (Associate, Real Estate, Düsseldorf) und Dr. Lukas Wasylow-Neuhaus (Associate, Öffentliches Recht, Düsseldorf)

    Berater Metro – Clifford Chance: Reinhard Scheer-Hennings (Partner, Federführung), Philip Heinzel (Senior Associate) und Maximilian Sablotny (Associate)

    About Us

    McDermott Will & Emery eine international führende Anwaltssozietät mit über 1.200 Anwältinnen und Anwälten an Standorten in Europa, Nordamerika und Asien. Wir arbeiten mit Führungskräften auf der ganzen Welt zusammen, um Missionen voranzutreiben, Barrieren zu überwinden und Märkte zu gestalten – unabhängig von Praxis- und Branchengrenzen. Unsere Anwältinnen und Anwälte decken mit ihrer Beratung das gesamte Spektrum des Wirtschafts- und Unternehmensrechts ab. Die deutsche Praxis wird von der McDermott Will & Emery Rechtsanwälte Steuerberater LLP geführt.

    Dr. Ulrich Flege

    Partner

    Düsseldorf

    Dr. Florian Schiefer

    Partner

    Frankfurt

    Dr. Jens Ortmanns

    Partner

    Düsseldorf, Köln

    Dr. Alexa Ningelgen

    Partnerin

    Düsseldorf

    Alina Affeld

    Rechtsanwältin

    Düsseldorf

    Wir empfehlen Ihnen ebenfalls

  • McDermott Represents Iron Path Capital in its Platform Acquisiton with Capitol Pain Institute

    McDermott Represents Iron Path Capital in its Platform Acquisiton with Capitol Pain Institute

    DEAL RELEASE / PRESSEMITTEILUNGEN

    McDermott Represents Iron Path Capital in its Platform Acquisiton with Capitol Pain Institute

    July 1, 2022

    Read time: 3 min

    International law firm McDermott Will & Emery represented Iron Path Capital, a private equity firm focused on healthcare and specialty industrials, in connection with its platform acquisition of Austin Pain Acquisition, LLC and its subsidiary 9600 Feet Holdings, LLC, an organization providing management and other support services to interventional pain management provider, Capitol Pain Institute (CPI). This partnership will create a physician-led consolidation platform focused on delivering the highest quality care for patients with chronic pain. This transaction was announced June 23, 2022.

    The McDermott deal team was led by Krist Werling and David Ivill with key support from Joe Parise and Hunter Sharp. The cross-practice team included John Zukin, Brad Burcroff, Selina Ibarra, Alex Ruiz, Kwabena Yeboah, Jeffrey Holdvogt, Brian Mead, Jennifer Mikulina, Thomas DaMario, Jonathan Salm, Li Wang, Morgan Pollard, Tony Maida, Adetoro Olugbemi, Scott Weinstein, Jared Bryant, Caitlin Harrington, John Parker and Robin Riley.

    Read Iron Path Capital’s press release.

    McDermott’s private equity practice is among the top four most active PE law firms globally and in the US with more than 160 dedicated private equity lawyers in 21 locations globally. In addition to being Pitchbook’s top Healthcare PE firm for a fifth consecutive year and fifth in both IT and financial services private equity, we are named Energy & Industrials Law Firm of the Year (Large Cap) by The Deal, Top 10 in PE Buyouts by MergerMarket and Top 10 in US Mid-Market by Bloomberg. Learn more about our PE practice by visiting pe.mwe.com.

    About Us

    McDermott Will & Emery partners with leaders around the world to fuel missions, knock down barriers and shape markets. Our team works seamlessly across practices, industries and more than 20 locations to deliver highly effective solutions that propel success. More than 1,200 lawyers strong, we bring our personal passion and legal prowess to bear in every matter for our clients and the people they serve.

    Wir empfehlen Ihnen ebenfalls

  • McDermott Launches Austin Office with Prominent Intellectual Property Group

    McDermott Launches Austin Office with Prominent Intellectual Property Group

    PRESSEMITTEILUNGEN

    McDermott Launches Austin Office with Prominent Intellectual Property Group

    June 30, 2022

    Read time: 4 min

    International law firm McDermott Will & Emery is pleased to announce the opening of a new office in Austin, Texas, with a team of eight intellectual property (IP) partners: Kevin Meek, Syed Fareed, Stephen Hash, Paula Heyman, Brian Oaks, Margaret Sampson, Nick Schuneman and Brett Thompsen.

    “Austin is a vibrant and exciting market for both clients and top talent and we are delighted to be part of its strong growth trajectory—it’s a natural fit for us.” said Ira Coleman, McDermott’s Chairman. “In addition to this fantastic group of intellectual property expertise, there is also wonderful alignment with our power alley practices—particularly technology, healthcare and litigation—that we very much look forward to building on.”

    “We’re focused on growth across McDermott’s IP, transactions and litigation practices, with parallel concentration across the technology, health and life sciences industries,” Michael S. Poulos, McDermott’s head of strategy, added. “We’re excited that this tailor-made IP group is launching McDermott in Austin and have no doubt that we will have more expansion developments to announce in the very near term.”

    This group follows a series of strategic IP partner hires throughout 2021 including Simon Roberts, Jason Leonard, Maxwell “Mac” Fox, Douglas H. Carsten and Adam W. Burrowbridge.

    “Opening an office in the Western District of Texas allows us to take full advantage of the growing influx of patent case filings in Texas since the largest percentage of all district court patent litigation cases are now filed in Texas,” William Gaede, head of McDermott’s Global Intellectual Property Practice Group, noted. “This team of elite practitioners boosts our practice’s strength in both IP litigation and IP transactions and is a bold move advancing our remarkable IP practice into an industry powerhouse. We are excited to see what the coming months bring as we welcome the team to our global IP platform.”

    Kevin Meek will be appointed as the office managing partner of the new office. Health partner Amanda K. Jester will also relocate from our Dallas to Austin office at opening.

    “This is an incredible opportunity for this team to lay the foundation of a new office in a booming IP market and the Firm has given us the platform and support to make this both a near term and long-term success,” Kevin said. “Our group was initially attracted to McDermott’s global reach and the sophisticated legal talent of our new colleagues, and once we began conversations with the Firm, there were simply too many current and prospective client- and cross-practice synergies to count. We knew right away that joining McDermott just made sense.”

    The Austin launch brings McDermott’s total global office locations to 22. Read more about the Austin office.

    About Us

    McDermott Will & Emery partners with leaders around the world to fuel missions, knock down barriers and shape markets. With more than 20 locations on three continents, our team works seamlessly across practices, industries and geographies to deliver highly effective solutions that propel success. More than 1,200 lawyers strong, we bring our personal passion and legal prowess to bear in every matter for our clients and the people they serve.

    Wir empfehlen Ihnen ebenfalls

  • McDermott Represents Sterling Partners in Platinum Dermatology and West Dermatology Merger

    McDermott Represents Sterling Partners in Platinum Dermatology and West Dermatology Merger

    DEAL RELEASE / PRESSEMITTEILUNGEN

    McDermott Represents Sterling Partners in Platinum Dermatology and West Dermatology Merger

    June 23, 2022

    Read time: 3 min

    International law firm McDermott Will & Emery represented Sterling Partners (Sterling), a diversified investment management platform, in its business combination with Sun Capital Partners (Sun Capital), a leading healthcare services investor, to merge Sun Capital’s portfolio company, West Dermatology and Sterling’s portfolio company, Platinum Dermatology Partners.

    About Us

    McDermott Will & Emery partners with leaders around the world to fuel missions, knock down barriers and shape markets. Our team works seamlessly across practices, industries and more than 20 locations to deliver highly effective solutions that propel success. More than 1,200 lawyers strong, we bring our personal passion and legal prowess to bear in every matter for our clients and the people they serve.

    Wir empfehlen Ihnen ebenfalls

  • McDermott berät SüdBG beim Erwerb einer Beteiligung an Sovereign Speed

    DEAL RELEASE / PRESSEMITTEILUNGEN

    McDermott berät SüdBG beim Erwerb einer Beteiligung an Sovereign Speed

    23. Juni 2022

    Read time: 3 min

    Frankfurt a.M., 23. Juni 2022 — McDermott Will & Emery hat die Süd Beteiligungen GmbH (SüdBG) beim Erwerb einer Beteiligung an der Sovereign Speed Holding GmbH beraten. Die Transaktion steht noch unter dem Vorbehalt der Genehmigung durch die Kartellbehörden.

    Die bisherigen Gesellschafter Karim El-Sayegh und Martin Araman bleiben auch in Zukunft maßgeblich an dem Unternehmen beteiligt. Der langjährige CEO Frank Liebelt tritt im Zuge der Transaktion neu dem Gesellschafterkreis bei.

    Die Sovereign Speed Holding GmbH, gegründet 1998 in Hamburg, bietet Frachtdienste im B2B-Bereich in Europa an. Mit rund 770 Mitarbeitern an 14 Standorten erwirtschaftet das Unternehmen einen Umsatz von über 100 Mio. Euro.

    Die Süd Beteiligungen GmbH mit Sitz in Stuttgart ist eine 100prozentige Tochtergesellschaft der Landesbank Baden-Württemberg (LBBW). Die SüdBG unterstützt mittelständische Unternehmen seit über 40 Jahren mit Eigenkapitallösungen im Rahmen von Nachfolgeregelungen, Wachstumsfinanzierungen und Gesellschafterwechseln.

    Berater Süd Beteiligungen GmbH:
    McDermott Will & Emery, Frankfurt: Dr. Michael Cziesla (Federführung), Dr. Christian Marzlin (Counsel; beide Corporate/M&A), Dr. Heiko Kermer, Marcus Fischer (Counsel; beide Steuerrecht), Dr. Christian Rolf (Arbeitsrecht), Dr. Alexa Ningelgen (Regulatory, Düsseldorf); Associates: Isabelle Müller, Lisa Schickling (beide Corporate/M&A), Dr. Lukas Wasylow-Neuhaus, Lene Niemeier, Dr. Tim Weill (alle Regulatory, Düsseldorf).
    Das Team wurde zudem von weiteren Mitgliedern aus den McDermott Büros in Frankreich und dem Vereinigten Königreich unterstützt.

    About Us

    McDermott Will & Emery eine international führende Anwaltssozietät mit über 1.200 Anwältinnen und Anwälten an Standorten in Europa, Nordamerika und Asien. Wir arbeiten mit Führungskräften auf der ganzen Welt zusammen, um Missionen voranzutreiben, Barrieren zu überwinden und Märkte zu gestalten – unabhängig von Praxis- und Branchengrenzen. Unsere Anwältinnen und Anwälte decken mit ihrer Beratung das gesamte Spektrum des Wirtschafts- und Unternehmensrechts ab. Die deutsche Praxis wird von der McDermott Will & Emery Rechtsanwälte Steuerberater LLP geführt.

    Dr. Heiko Kermer

    Partner

    Frankfurt

    Dr. Alexa Ningelgen

    Partnerin

    Düsseldorf

    Dr. Christian Marzlin

    Partner

    Frankfurt

    Marcus Fischer

    Counsel

    Frankfurt

    Isabelle Suzanne Gvero

    Counsel

    Frankfurt

    Lene Niemeier

    Rechtsanwältin

    Düsseldorf

    Wir empfehlen Ihnen ebenfalls

  • McDermott Represents Future Health in Acquisition of Excelera

    McDermott Represents Future Health in Acquisition of Excelera

    DEAL RELEASE / PRESSEMITTEILUNGEN

    McDermott Represents Future Health in Acquisition of Excelera

    June 16, 2022

    Read time: 3 min

    International law firm McDermott Will & Emery represented Future Health ESG Corp. (NASDAQ: FHLT), a special purpose acquisition company, in its acquisition of Excelera DCE, a leading Accountable Care Organization and AI Platform. This merger supports the expansion of Excelera’s science-driven approach to managing care for seniors and is expected to be listed on NASDAQ under “XLRA”.

    • The transaction was announced on June 14, 2022.
    • The deal values Excelera at $459 million, the companies said, adding it is expected to provide up to $282 million to accelerate expansion of Excelera’s network. Upon completion of the transaction, the combined company is expected to operate as Excelera Health, Inc. and Excelera’s existing management team will continue to lead the Company following the transaction.
    • The McDermott team was led by Ari Edelman, Jeremy Earl and Sunyi Snow and included Matt Perreault, Jason Kramer, Caroline Samuelson, Yuxin Jin, Emily Curran, Ryan Houseal, Marchan Clark, Kwabena Yeboah, Cristell Fortune, Li Wang, Steve Hadjilogiou and Michelle Strowhiro.
    • Read Future Health and Excelera’s combined press release.
    About Us

    McDermott Will & Emery partners with leaders around the world to fuel missions, knock down barriers and shape markets. Our team works seamlessly across practices, industries and more than 20 locations to deliver highly effective solutions that propel success. More than 1,200 lawyers strong, we bring our personal passion and legal prowess to bear in every matter for our clients and the people they serve.

    Wir empfehlen Ihnen ebenfalls